NCI and FDA Perspective, PublicationsPancarcinoma T/Tn Antigen Detects Human Carcinoma Long before Biopsy Does and Its Vaccine Prevents Breast Carcinoma Recurrence
NCI and FDA Perspective, PublicationsActive Specific Immunotherapy of Hadgkin’s Lymphoma by an Anti-Idiotype Vaccine against the Hodgkin-Associated CD30 Antigen
NCI and FDA Perspective, PublicationsTransfection of TGF-B Producing Tumors with IL-2 Elicits Tumor Rejection
Approaches for Potentiating, PublicationsAugmentation of T-Cell Response with a Melanoma Cell Vaccine Expressing Specific HLA-A Antigens
Approaches for Potentiating, PublicationsAssesment of Immunologic Competence and Host Reactivity against Tumor Antigens in Breast Cancer Patients
Approaches for Potentiating, PublicationsImmunization Effect of Monoclonal Antibodies against Tumor-Associated Antigens during Cancer Treatment
Approaches for Potentiating, PublicationsImmunization with Human Monoclonal Antiidiotypic Antibody in Colorectal Cancer
Approaches for Potentiating, PublicationsActive Specific Immunotherapy of Murine Colon Adenocarcinoma with Recombinant Vaccinia/Interleukin-2-Infected Tumor Cell Vaccines
Approaches for Potentiating, PublicationsCancer Vaccines: The Perspective of the Cancer Immunology Branch, NCI
Publications, Rationale for VaccineImmune Responses of Mice and Human Breast Cancer Patients Following Immunization with Synthetic Sialyl-Tn Conjugated to KLH Plus Detox Adjuvant
Publications, Rationale for VaccineNovel Adjuvent Strategies for Experimental Malaria and AIDS Vaccines
Human Tumor Antigens, PublicationsSpecific and Effective T-Cell Recognition of Cells Transfected with a Truncated Human Mucin cDNA
